Status: Not yet recruiting
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
This study is looking at how safe BHB810 is in adults with gastric and gastroesophageal adenocarcinoma (GEJ). The purpose of this study is also to look at: how well the study drug works, how the study drug moves into, through, and out of the body, and how your body reacts to the study drug. Participants will get an IV infusion of BHB810 every 2 weeks while on study treatment.
Participants needed: 164
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: BigHat Biosciences, Inc.Updated: May 8, 2026
Eligibility criteria
Participant must be ≥ 18 years or the legal age of consent in the jurisdiction i... [+6]
Chemotherapy or targeted therapy withing 4 weeks or 5-halflives (whichever is sh... [+11]